At the time of writing, CVS Health Corp [CVS] stock is trading at $78.66, up 0.14%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The CVS shares have gain 2.57% over the last week, with a monthly amount glided 2.25%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
CVS Health Corp [NYSE: CVS] stock has seen the most recent analyst activity on October 14, 2025, when Goldman initiated its Buy rating and assigned the stock a price target of $91. Previously, UBS upgraded its rating to Buy on August 18, 2025, and kept the price target unchanged to $79. On August 14, 2025, upgrade upgraded it’s rating to Outperform but maintained its price target of $82 on the stock. Leerink Partners upgraded its rating to an Outperform and increased its price target to $75 on February 13, 2025. Cantor Fitzgerald upgraded its rating to a Overweight. Edward Jones upgraded its rating to Buy for this stock on January 30, 2025. In a note dated December 03, 2024, Deutsche Bank upgraded a Buy rating on this stock but restated the target price of $66.
For the past year, the stock price of CVS Health Corp fluctuated between $43.56 and $85.15. Currently, Wall Street analysts expect the stock to reach $91.22 within the next 12 months. CVS Health Corp [NYSE: CVS] shares were valued at $78.66 at the most recent close of the market. An investor can expect a potential return of 15.97% based on the average CVS price forecast.
Analyzing the CVS fundamentals
According to CVS Health Corp [NYSE:CVS], the company’s sales were 393.94B for trailing twelve months, which represents an 7.83% jump. Gross Profit Margin for this corporation currently stands at 0.14% with Operating Profit Margin at 0.01%, Pretax Profit Margin comes in at 0.01%, and Net Profit Margin reading is 0.0%. To continue investigating profitability, this company’s Return on Assets is posted at 0.0, Equity is 0.01 and Total Capital is 0.03. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.12.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 78.18 points at the first support level, and at 77.69 for the second support level. However, for the 1st resistance point, the stock is sitting at 79.50, and for the 2nd resistance point, it is at 80.34.
Ratios To Look Out For
It is important to note that CVS Health Corp [NYSE:CVS] has a current ratio of 0.83. Further, the Quick Ratio stands at 0.63, while the Cash Ratio is 0.1. Considering the valuation of this stock, the price to sales ratio is 0.25, the price to book ratio is 1.37 and price to earnings (TTM) ratio is 205.54.
Transactions by insiders
Recent insider trading involved Finucane Anne A., Director, that happened on Aug 20 ’25 when 7500.0 shares were sold. Director, Finucane Anne A. completed a deal on Aug 20 ’25 to buy 7500.0 shares. Meanwhile, Director SANSONE GUY P bought 1570.0 shares on Jun 05 ’25.
